BlackRock’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Buy
23,667
+1,597
+7% +$15.9K ﹤0.01% 4753
2025
Q4
$184K Sell
22,070
-145
-0.7% -$1.46K ﹤0.01% 4744
2025
Q3
$267K Sell
22,215
-156
-0.7% -$1.91K ﹤0.01% 4621
2025
Q2
$190K Buy
22,371
+198
+0.9% +$2.02K ﹤0.01% 4683
2025
Q1
$251K Sell
22,173
-3,267
-13% -$59.3K ﹤0.01% 4558
2024
Q4
$519K Buy
25,440
+3,171
+14% +$92.5K ﹤0.01% 4404
2024
Q3
$884K Buy
22,269
+397
+2% +$10.7K ﹤0.01% 4205
2024
Q2
$385K Buy
21,872
+4,123
+23% +$69.8K ﹤0.01% 4410
2024
Q1
$295K Sell
17,749
-71
-0.4% -$1.03K ﹤0.01% 4507
2023
Q4
$337K Sell
17,820
-36
-0.2% -$676 ﹤0.01% 4522
2023
Q3
$371K Buy
17,856
+5,940
+50% +$180K ﹤0.01% 4504
2023
Q2
$651K Buy
11,916
+3,160
+36% +$97.2K ﹤0.01% 4412
2023
Q1
$158K Sell
8,756
-14
-0.2% -$241 ﹤0.01% 4840
2022
Q4
$89K Sell
8,770
-19
-0.2% -$203 ﹤0.01% 5079
2022
Q3
$116K Sell
8,789
-28
-0.3% -$424 ﹤0.01% 5134
2022
Q2
$113K Buy
8,817
+82
+0.9% +$2.17K ﹤0.01% 5206
2022
Q1
$453K Buy
8,735
+9
+0.1% +$381 ﹤0.01% 4901
2021
Q4
$394K Buy
8,726
+67
+0.8% +$3.59K ﹤0.01% 4941
2021
Q3
$568K Buy
8,659
+21
+0.2% +$1.59K ﹤0.01% 4722
2021
Q2
$865K Sell
8,638
-35,997
-81% -$3.71M ﹤0.01% 4559
2021
Q1
$5.7M Buy
44,635
+1,081
+2% +$160K ﹤0.01% 3881
2020
Q4
$4.84M Buy
43,554
+2,434
+6% +$273K ﹤0.01% 3726
2020
Q3
$4.84M Sell
41,120
-728
-2% -$126K ﹤0.01% 3585
2020
Q2
$8.98M Buy
41,848
+3,167
+8% +$748K ﹤0.01% 3244
2020
Q1
$8.72M Buy
38,681
+551
+1% +$157K ﹤0.01% 3072
2019
Q4
$10.2M Buy
38,130
+3,418
+10% +$859K ﹤0.01% 3240
2019
Q3
$10.5M Buy
34,712
+1,445
+4% +$444K ﹤0.01% 3185
2019
Q2
$11M Buy
33,267
+3,666
+12% +$1.86M ﹤0.01% 3195
2019
Q1
$18.5M Buy
29,601
+209
+0.7% +$95.3K ﹤0.01% 2780
2018
Q4
$7.31M Buy
29,392
+108
+0.4% +$43K ﹤0.01% 3236
2018
Q3
$13.6M Buy
29,284
+230
+0.8% +$111K ﹤0.01% 3079
2018
Q2
$15.8M Buy
29,054
+1,340
+5% +$804K ﹤0.01% 2993
2018
Q1
$15.9M Sell
27,714
-4
-0% -$2.52K ﹤0.01% 2891
2017
Q4
$17.7M Buy
27,718
+217
+0.8% +$153K ﹤0.01% 2845
2017
Q3
$25.9M Buy
27,501
+142
+0.5% +$109K ﹤0.01% 2655
2017
Q2
$23.9M Sell
27,359
-165
-0.6% -$135K ﹤0.01% 2692
2017
Q1
$19M Buy
27,524
+27,480
+62,455% +$18.1M ﹤0.01% 2790
2016
Q4
$32K Sell
44
-7
-14% -$4.84K ﹤0.01% 3113
2016
Q3
$38K Buy
51
+3
+6% +$2.43K ﹤0.01% 3091
2016
Q2
$40K Buy
48
+22
+85% +$20.5K ﹤0.01% 3038
2016
Q1
$22K Buy
26
+17
+189% +$13.4K ﹤0.01% 2811
2015
Q4
$11K Hold
9
﹤0.01% 2855
2015
Q3
$8K Hold
9
﹤0.01% 2840
2015
Q2
$17K Sell
9
-2
-18% -$2.54K ﹤0.01% 2479
2015
Q1
$13K Hold
11
﹤0.01% 2591
2014
Q4
$12K Buy
11
+2
+22% +$2.05K ﹤0.01% 2661
2014
Q3
$9K Hold
9
﹤0.01% 2801
2014
Q2
$12K Hold
9
﹤0.01% 2667
2014
Q1
$12K Hold
9
﹤0.01% 2619
2013
Q4
$10K Hold
9
﹤0.01% 2721
2013
Q3
$11K Buy
+9
New +$6.11K ﹤0.01% 2587

Other funds holding RMTI

BlackRock's RMTI Position: Q1 2026 in Review

BlackRock increased its Rockwell Medical (RMTI) stake by 7.2% in Q1 2026, buying an estimated $15.9K and bringing the position to 23,667 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #4753.

BlackRock first reported a position in RMTI in Q3 2013 and has held it in 51 quarters since. The position peaked at $25.9M in Q3 2017. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • BlackRock held 23,667 shares of Rockwell Medical worth $211K as of Q1 2026.
  • BlackRock bought 1,597 Rockwell Medical shares in Q1 2026, an estimated $15.9K.
  • Rockwell Medical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4753 holding.
  • BlackRock first reported a position in Rockwell Medical in Q3 2013 and has held it in 51 quarters since.
  • BlackRock's Rockwell Medical position peaked at $25.9M in Q3 2017.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.